Effects of Tofacitinib (CP-690,550) on Magnetic Resonance Imaging (MRI)- Assessed Joint Structure In Early Rheumatoid Arthritis (RA)
Part of paid clinical trials in Gilbert, Arizona.
- Sponsor
- Pfizer
- Study ID
- NCT01164579
- Phase
- PHASE2
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Tasocitinib plus Methotrexate — DRUGTofacitinib (CP 690,550) 10 mg BID, tablets + methotrexate (MTX) 10 mg/wk to 20 mg/wk, titrated over 2 months
- Tofacitinib plus placebo methotrexate — DRUGTofacitinib (CP-90,550) 10 mg BID, tablets. Placebo to match methotrexate (MTX) capsules titrated as in Treatment Arm 1.
- Placebo tofacitinib plus Methotrexate — DRUGMethotrexate (MTX) 10 mg/wk to 20 mg/wk, capsules, titrated over 2 months. Placebo in tablets to match tofacitinib
Study Details
Evaluation of efficacy and safety of tofacitinib (CP-690,550) for the treatment of early rheumatoid arthritis in adult patients with moderate to severe disease who are methotrexate naïve. The efficacy will be evaluated by exploring the effects on joint structure assessed by magnetic resonance imaging, x-rays and by standard clinical assessment.
Key Dates
- Start date
- Oct 31, 2010
- Status verified
- Apr 2015
- Primary completion
- Nov 30, 2013
- Completion
- Nov 30, 2013
Study Design
- Enrollment
- 109 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Tofacitinib (CP 690,550) 10 mg BID plus MTX
- Experimental: Tofacitinib (CP-690,550) 10 mg BID, tablet plus placebo MTX
- Active Comparator: Placebo tofacitinib (CP-690,55) plus MTX 10 mg/wk to 20 mg/wk
Primary Outcome Measure
Change From Baseline to Month 3 in Outcome Measures in Rheumatoid Arthritis Clinical Trials (OMERACT) Rheumatoid Arthritis Magnetic Resonance Imaging Score (RAMRIS) Wrist and Metacarpophalangeal (MCP) Synovitis [ Time Frame: Month 3 ]
Locations (8)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| ArthroCare, Arthritis Care & Research, PC | Gilbert | Arizona | 85234 | - |
| Talbert Medical Group | Huntington Beach | California | 92646 | - |
| Inland Rheumatology Clinical Trials, Inc. | Upland | California | 91786 | - |
| Millennium Research | Ormond Beach | Florida | 32174 | - |
| DMI Research, Inc. | Pinellas Park | Florida | 33782 | - |
| St. Petersburg Arthritis Center | St. Petersburg | Florida | 33710 | - |
| Oklahoma Medical Research Foundation | Oklahoma City | Oklahoma | 73104 5005 | - |
| Office of John P. Lavery, MD, PA | Allen | Texas | 75013 | - |
Find similar trials in Gilbert, AZ
By condition
Related Studies
- Physica System Total Knee Replacement Registry StudyRecruiting · Limacorporate S.p.a · Rancho Mirage, California
- Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVOPHASE1 · Recruiting · National Cancer Institute (NCI) · Birmingham, Alabama
- RA-PRO PRAGMATIC TRIALPHASE3 · Recruiting · University of Alabama at Birmingham · Auburn, Alabama
- Effect of Anti-inflammatory Diet in Rheumatoid ArthritisRecruiting · University of California, San Diego · La Jolla, California